During Monday’s Current trade, Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), lost -7.23% to $3.08.
Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, declared that the central patent for Zohydro ER(R) with BeadTek(TM), U.S. Patent Number 9,132,096, has issued. The patent covers a formulation of a combination of inactive beads with BeadTek abuse deterrent technology and active hydrocodone beads and expires in September 2034. In addition, Zohydro ER with BeadTek will be added to the U.S. Food and Drug Administration’s (FDA) Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as “the Orange Book”), which identifies drug products approved on the basis of safety and effectiveness by the FDA.
BeadTek is a technology that encompasses an indistinguishable mix of inactive beads, active immediate release hydrocodone beads and active extended-release hydrocodone beads. Zohydro ER with BeadTek was approved on January 30, 2015 by the FDA. Zohydro ER with BeadTek delivers an extended release of hydrocodone that provides 12-hour dose duration. When the medication is taken as directed, the inactive beads contained in Zohydro ER with BeadTek remain inert. The inactive beads dissolve independently of the active hydrocodone beads and are designed not to change the 12-hour release properties of the medication. However, when crushed and dissolved in liquids or solvents, the inactive beads are designed to right away form a viscous gel.
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product comprise CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product.
UDR, Inc. (NYSE:UDR), during its Monday’s current trading session decreased -1.69% to $33.22.
UDR, Inc. (NYSE: UDR), a leading multifamily real estate investment trust, declared that its Board of Directors declared a regular quarterly dividend on its common stock for the third quarter of 2015 in the amount of $0.2775 per share, payable in cash, on November 2, 2015 to UDR common stock shareholders of record as of October 12, 2015. The November 2nd dividend will be the 172nd successive quarterly dividend paid by the Company on its common stock.
UDR, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It owns, operates, acquires, renovates, develops, redevelops, and manages multifamily apartment communities.
Finally, Pentair plc. Ordinary Share (NYSE:PNR), decreased -0.46%, to $51.74.
Pentair, a global leader in the treatment, transfer and flow of water and other fluids, is showcasing its latest innovations and integrated solutions at the Water Environment Federation`s Annual Technical Exhibition (WEFTEC) in Chicago, September 28 - 30, 2015. As a leader in assisting to manage the world`s precious water resources, Pentair provides a global perspective and depth of expertise across industries to assist its customers do more with accessible water, whether it`s filtering drinking water, treating wastewater for reuse or the safe return to the environment, in addition to assisting to manage bodies of water.
Pentair experts will be sharing industry best practices and insights at presentations and demonstrations during the exhibition. Ronald Van `t Oever, Global Product Manager - Pentair Flow & Filtration Solutions, will highlight a recent water reuse project at a Steam Assisted Gravity Drainage (SAGD) oil field near Moscow in his presentation about the latest advances in oil production wastewater administration and purification. Show attendees can also attend the operateshop, “Pump Design, Application, Maintenance and Troubleshooting,” hosted by Zeki Okan Oral, Director of Global Product Administration - Pentair Flow & Filtration Solutions.
Pentair plc operates as a diversified industrial manufacturing company in the United States, Europe, and internationally. The company operates through Valves & Controls, Technical Solutions, Flow & Filtration Solutions, and Water Quality Systems segments. It designs, manufactures, markets, and services valves, fittings, automation and controls, and actuators, in addition to provides engineering, design, inspection, maintenance, and repair services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
